INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS)
CUSIP: 45828J103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 48,324,727
- Total 13F shares
- 1,978,698
- Share change
- -609,761
- Total reported value
- $606,612
- Price per share
- $0.31
- Number of holders
- 27
- Value change
- -$1,718,334
- Number of buys
- 17
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 45828J103?
CUSIP 45828J103 identifies INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45828J103:
Top shareholders of INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SAPIENT CAPITAL LLC |
13F
13D/G
|
Company |
3.9%
from 13D/G
|
976,797
|
$1,924,290 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
2.6%
from 13D/G
|
872,547
|
$1,718,918 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.48%
|
230,659
|
$454,398 | — | 31 Mar 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.27%
|
130,072
|
$256,242 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
77,482
|
$152,655 | — | 31 Mar 2025 | |
| Sigma Planning Corp |
13F
|
Company |
0.11%
|
54,837
|
$108,029 | — | 31 Mar 2025 | |
| Mesirow Financial Investment Management, Inc. |
13F
|
Company |
0.08%
|
40,000
|
$78,800 | — | 31 Mar 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.08%
|
37,805
|
$74,476 | — | 31 Mar 2025 | |
| One Charles Private Wealth Services, LLC |
13F
|
Company |
0.07%
|
31,800
|
$62,646 | — | 31 Mar 2025 | |
| Rothschild Wealth LLC |
13F
|
Company |
0.06%
|
27,304
|
$53,789 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
25,801
|
$50,828 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.05%
|
21,835
|
$43,014 | — | 31 Mar 2025 | |
| QTR Family Wealth, LLC |
13F
|
Company |
0.04%
|
17,420
|
$34,317 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
14,500
|
$28,565 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
14,024
|
$27,627 | — | 31 Mar 2025 | |
| Stonebridge Financial Group, LLC |
13F
|
Company |
0.02%
|
9,525
|
$18,764 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,097
|
$6,101 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,376
|
$4,681 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
500
|
$985 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
63
|
$124 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
15
|
$30 | — | 31 Mar 2025 | |
| Daniel Donovan |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 02 May 2025 | |
| Dr. Emer Leahy |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 02 May 2025 | |
| Mark A. Goldberg |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 02 May 2025 | |
| Thomas I. H. Dubin |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 02 May 2025 |
Institutional Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q2 2025
As of 30 Jun 2025,
INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,978,698 shares.
The largest 10 holders included
SAPIENT CAPITAL LLC, Sentinus, LLC, BROWN ADVISORY INC, Mesirow Financial Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, Sigma Planning Corp, Warberg Asset Management LLC, JANE STREET GROUP, LLC, VANGUARD GROUP INC, and BLAIR WILLIAM & CO/IL.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
21
Q2 2025 holders
27
Holder diff
6
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.